Perspective of patients with autoimmune diseases on COVID-19 vaccination

Benzer Materyaller

• Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
  Yazar:: Boekel, Laura, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
  Yazar:: Hooijberg, Femke, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Response to “Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing”
  Yazar:: van Kempen, Zoé LE, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis
  Yazar:: Stefan P. H. van denBerg, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-06-01)
• Infusion-related events during natalizumab: No need for post-infusion monitoring
  Yazar:: Loonstra, Floor C, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)